Aurobindo Pharma Ltd share price logo

Aurobindo Pharma Ltd

NSE: AUROPHARMA

BSE: 524804

Mid Cap

Healthcare Sector

Pharma Sector

₹1463.50

-83.20

(-5.38%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Expansion Alert

Aurobindo Pharma expands biologics pipeline with 15 products, plans new manufacturing facilities and expects FY27 margins above 21%

Aurobindo Pharma Stock Performance

as on May 22, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,445.80
    ₹1,520.00
    downward going graph

    1.21%

    Downside

    3.86%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,016.10
    ₹1,539.00
    downward going graph

    30.57%

    Downside

    5.16%

    Upside

    downward going graph

Aurobindo Pharma share price movements today

Previous Close
₹1,546.70
Open
₹1,520.00
Volume
30.39L
Upper Circuit
₹1,701.30
Lower Circuit
₹1,392.10
Day's Low - High
₹1,445.80 - ₹1,520.00
52 Week Low - High
₹1,016.10 - ₹1,539.00

Aurobindo Pharma Historical Returns

1 Month Return
+ 8.83 %
3 Month Return
+ 34.43 %
1 Year Return
+ 30.17 %
3 Year Return
+ 156.61 %
5 Year Return
+ 52.57 %

Aurobindo Pharma Fundamentals

as on May 22, 2026 at 4:01 pm IST

Market Cap

₹89,832.59 Cr

Return on Equity (ROE)

8.68

PE Ratio (TTM)

25.63

Return on capital employed (ROCE)

10.82

Industry PE ratio

46.14

Beta (LTM)

0.6

P/B Ratio

3.28

Dividend Yield

0

PEG Ratio

48.36

Quarterly Earnings Growth YOY

1.99

EPS (TTM)

59.98

Sector

Pharmaceuticals

Book Value

562.21

Aurobindo Pharma Stock Valuation

as on May 22, 2026 at 4:01 pm IST

Aurobindo Pharma in the last 5 years

  • Overview

  • Trends

Lowest (6.73x)

March 23, 2020

Today (25.63x)

May 21, 2026

Industry (46.14x)

May 21, 2026

Highest (27.59x)

December 21, 2023

LowHigh

Today’s Price to Earnings Ratio: 25.63x

Aurobindo Pharma Technical Analysis

Track how Aurobindo Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish2
Bullish11
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
5.35
Bullish
CCI (20)
182.82
Bearish
RSI (14)
63.63
Neutral
Momentum (10)
11.8
Bearish
ADI (14)
53.76
Bullish
Ultimate Oscillator (7,14,28)
45.86
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1462.82
Bullish
EMA (20)
1464.16
Bullish
VWMA (20)
1466.26
Bullish
SMA (50)
1455.28
Bullish
EMA (50)
1458.26
Bullish
SMA (200)
1453.85
Bullish
EMA (200)
1458.31
Bullish
KAMA (200)
1460.88
Bullish
DEMA (200)
1448.11
Bullish

Aurobindo Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aurobindo Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY89,832.5910.51%0.603,48331,723
Sanofi India Ltd image
Sanofi India Ltd
BUY7,348.87-11.75%0.004132,013
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD1,04,291.1213.37%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY58,894.3814.29%0.001,4146,445
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY39,314.0611.63%0.569273,749
See all

Market expectation of Aurobindo Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

80.77%

Buy

3.85%

Hold

15.38%

Sell

Aurobindo Pharma Stock’s Investor Sentiment and Interest

Investment in Aurobindo Pharma Ltd Shares on INDmoney has dropped by -4.50% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-4.50% versus previous 30 day period

Search interest for Aurobindo Pharma Ltd Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-15% versus previous 30 day period

Aurobindo Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
6,790.64
7,150.71
7,271.23
7,491.92
7,457.65
7,646.21
7,893.15
8,381.12
7,791.77
8,236.96
8,604.51
8,751.5
Other Income
116.33
187.88
162.52
135.62
220.93
136.3
158.88
134.81
107.22
122.25
188.01
117.04
Total Income
6,966.85
7,407.3
7,514.3
7,715.77
7,787.95
7,932.37
8,137.4
8,516.93
7,975.36
8,407.95
8,833.91
8,970.38
Expenses
5,771.71
5,845.98
5,753.06
6,042.11
5,948.84
6,229.93
6,400.54
6,622.39
6,265.11
6,607.6
6,937.89
7,102.99
Operating Profit
1,018.93
1,304.73
1,518.17
1,449.81
1,508.81
1,416.28
1,492.61
1,758.73
1,526.66
1,629.36
1,666.62
1,648.51
Operating Profit Margin %
15%
18.25%
20.88%
19.35%
20.23%
18.52%
18.91%
20.98%
19.59%
19.78%
19.37%
18.84%
Profit Before Interest, Tax and Depreciation
1,195.14
1,561.32
1,761.24
1,673.66
1,839.11
1,702.44
1,736.86
1,894.54
1,710.25
1,800.35
1,896.02
1,867.39
Interest
56.55
68.18
75.55
89.43
111.04
112.7
118.48
115.02
97.75
95.24
92.77
98.21
Depreciation
326.56
417.5
423.27
354.33
404.18
382.28
418.53
444.43
405.7
429.19
464.73
478.57
Profit Before Tax
812.03
1,075.64
1,262.42
1,229.9
1,323.89
1,207.46
1,199.85
1,335.09
1,206.8
1,275.92
1,338.52
1,290.61
Tax Paid
242.32
323.7
322.45
322.55
405.67
390.51
354.28
432.26
382.6
427.79
428.72
369.77
Profit After Tax
569.71
751.94
939.97
907.35
918.22
816.95
845.57
902.83
824.2
848.13
909.8
920.84
Total Net profit including share of profit / Loss from associate company
569.71
751.94
939.97
907.35
918.22
816.95
845.57
902.83
824.2
848.13
909.8
920.84
EPS
9.74
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
Actual EPS
9.74
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
Adjusted EPS
9.74
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
Diluted EPS
9.74
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86

Aurobindo Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
16,232.87
19,225.92
22,737.95
24,557.95
23,366.55
24,617.13
28,704.5
31,378.13
33,384.74
Other Income
105.12
118.36
86.2
3,195.42
320.35
290.59
557.38
621.85
493.61
Total Income
16,604.96
19,681.91
23,184.7
27,970.05
23,775.84
25,145.97
29,559.25
32,345.58
34,146.69
Expenses
12,728.08
15,759.95
18,315.2
19,496.58
19,227.94
21,148.41
23,367.89
25,172.63
26,872.68
Operating Profit
3,504.79
3,465.97
4,422.75
5,061.37
4,138.61
3,468.72
5,336.61
6,205.5
6,512.06
Operating Profit Margin %
21.59%
18.03%
19.45%
20.61%
17.71%
14.09%
18.59%
19.78%
19.51%
Profit Before Interest, Tax and Depreciation
3,876.88
3,921.96
4,869.5
8,473.47
4,547.9
3,997.56
6,191.36
7,172.95
7,274.01
Interest
77.71
162.66
159.77
74.49
48.64
140.48
289.71
457.24
383.97
Depreciation
557.97
667.95
966.71
1,055.38
1,126.52
1,244.58
1,521.66
1,649.42
1,778.19
Profit Before Tax
3,241.2
3,091.35
3,743.02
7,343.6
3,372.74
2,612.5
4,379.99
5,066.29
5,111.85
Tax Paid
818.28
726.85
913.51
2,009.77
725.63
684.85
1,211.02
1,582.72
1,608.88
Profit After Tax
2,422.92
2,364.5
2,829.51
5,333.83
2,647.11
1,927.65
3,168.97
3,483.57
3,502.97
Total Net profit including share of profit / Loss from associate company
2,422.92
2,364.5
2,829.51
5,333.83
2,647.11
1,927.65
3,168.97
3,483.57
3,502.97
EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Actual EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Adjusted EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Diluted EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34

Aurobindo Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,419.76
3,278.58
1,954.52
1,650.97
4,381.28
3,329.05
5,016.48
2,386.75
2,434.52
3,924.62
Cash Flow from Investing Activities
-1,445.51
-1,787.18
-1,926.76
-2,904.39
-1,562.86
596.57
-3,211.36
-3,971.4
-4,241.78
-1,866.04
Cash Flow from Financing Activities
365.44
-1,915.26
864.15
1,919.06
-1,947.18
-1,364.94
-2,969.27
1,814.41
800.42
119.78
Net Cash Flow
339.69
-423.86
891.91
665.64
871.24
2,560.68
-1,164.15
229.76
-1,006.84
2,178.36

Mutual Funds that own Aurobindo Pharma Stock

Check out the Mutual Funds with significant holdings in Aurobindo Pharma.

Aurobindo Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Aurobindo Pharma.

  • Aurobindo Pharma Ltd Earnings Results

    Aurobindo Pharma Ltd’s net profit jumped 1.97% since last year same period to ₹921.26Cr in the Q4 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 1.21% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Aurobindo Pharma Ltd Dividends August,2025

    In the quarter ending June 2025, Aurobindo Pharma Ltd has declared dividend of ₹4.00 per share on 04 Aug 2025 - translating a dividend yield of 0.26%.

    Read More about Dividends

Aurobindo Pharma News & Key Events

  • img

    Today's Timeline - 22 May

    11:10 AM

    -

    Aurobindo Pharma's biologics pipeline includes 15 products across oncology, immunology, and respiratory therapies, expanding beyond conventional generics.

    12:44 PM

    -

    Aurobindo Pharma establishes new subsidiary in France to enhance manufacturing capabilities for generic formulations.

    01:19 PM

    -

    Aurobindo Pharma reports 2% profit rise but shares fall 6% due to weaker margins and mixed regional performance.

Indices Featuring Aurobindo Pharma Stock

Check stock indices that include Aurobindo Pharma.

Nifty Midcap 50

₹17,478.25

0.14 (▲24.15%)

NIFTY PHARMA

₹24,573.95

-1.27 (▲316.95%)

S&P BSE MidCap Select

₹17,397.06

0.30 (▲51.93%)

BSE 200

₹11,047.96

0.30 (▲32.51%)

BSE Healthcare

₹47,267.53

-1.23 (▲589.53%)

Nifty LargeMidcap 250

₹16,298.85

0.20 (▲32.65%)

BSE 500

₹35,413.94

0.21 (▲73.63%)

S&P BSE 250 LargeMidCap

₹10,517.28

0.26 (▲27.34%)

Nifty 500

₹22,651.30

0.21 (▲48.45%)

Nifty 200

₹13,675.90

0.27 (▲36.30%)

Nifty Midcap Sel

₹14,381.55

0.21 (▲29.65%)

Nifty Healthcare

₹15,671.20

-1.52 (▲242.55%)

S&P BSE 400 MidSmallCap

₹12,125.40

-0.01 (▲1.27%)

Nifty Midcap 100

₹61,389.30

0.14 (▲88.70%)

Nifty MidSmallcap 400

₹20,387.65

0.03 (▲6.65%)

S&P BSE 150 MidCap

₹16,374.34

0.11 (▲18.35%)

Nifty Midcap 150

₹22,504.20

0.11 (▲25.05%)

Insights on Aurobindo Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.55% to 7.08% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 824.75 Cr → 921.26 Cr (in ₹), with an average increase of 3.6% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 13.94% to 15.24% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, AUROPHARMA stock has moved up by 34.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 7.97K Cr → 8.97K Cr (in ₹), with an average increase of 3.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 39.1% return, outperforming this stock by 9.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.82% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 167.6% return, outperforming this stock by 11.0%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 19.52% to 17.79% in Mar 2026 quarter

Aurobindo Pharma Stock Futures & Options Contracts

View the latest movement in Aurobindo Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Aurobindo Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
AUROPHARMA 26 May ₹1500 Call
May 26, 2026
₹1500
₹5.7
-54.7
-90.56%
AUROPHARMA 26 May ₹1480 Call
May 26, 2026
₹1480
₹11.1
-66.75
-85.74%
AUROPHARMA 26 May ₹1460 Call
May 26, 2026
₹1460
₹21
-76.3
-78.42%
AUROPHARMA 26 May ₹1560 Call
May 26, 2026
₹1560
₹1.4
-27.5
-95.16%

Aurobindo Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
AUROPHARMA 30 Jun Fut
June 30, 2026
-
₹1477.9
-79.1
-5.08%
AUROPHARMA 26 May Fut
May 26, 2026
-
₹1467.5
-80.33
-5.19%
AUROPHARMA 28 Jul Fut
July 28, 2026
-
₹1483.8
-75.3
-4.83%

About Aurobindo Pharma Ltd

Aurobindo Pharma Ltd is an Indian multinational pharmaceutical company incorporated in 1986. Aurobindo Pharma operates in several lines of business including APIs, generics, biosimilars, advanced drugs, and consumer healthcare.

The company is well known for its top products such as antibiotics, anti-malarials, cardiovascular, and anti-diabetic drugs. Its popular brands include Aurolife, Aurocare, Aurochem, and Aurovit. Aurobindo Pharma is one of the largest manufacturers of generic drugs in India, with a presence in over 150 countries worldwide.

Revenue: ₹8,751.50Cr as on March 2026 (Q4 FY26)
Net Profit: ₹920.84Cr as on March 2026 (Q4 FY26)
Listing date: 19 Oct, 1995
Chairperson Name: K Ragunathan
OrganisationAurobindo Pharma Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOK Ragunathan
E-voting on sharesClick here to vote

FAQs

What is Aurobindo Pharma share price today?

Aurobindo Pharma share price today stands at ₹1463.5 as on at the close of the market. Aurobindo Pharma share today touched a day high of ₹1520 and a low of ₹1445.8.

What is the 52 week high and 52 week low range for Aurobindo Pharma share?

Aurobindo Pharma touched a 52 week high of ₹1539 and a 52 week low of ₹1016.1. Aurobindo Pharma share price today i.e. is closed at ₹1463.5, which is -4.91% down from its 52 week high and 44.03% up from its 52 week low.

What is Aurobindo Pharma's market capitalisation today?

Aurobindo Pharma market capitalisation is ₹89,832.59 Cr as on .

How to buy Aurobindo Pharma shares?

To buy Aurobindo Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AUROPHARMA or Aurobindo Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aurobindo Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aurobindo Pharma trading volume today?

Aurobindo Pharma trading volume is 30.39L as on . This means that 30.39L shares of Aurobindo Pharma were bought and sold on the stock market during today's trading session.